Search
Menu
Hamamatsu Corp. - Earth Innovations LB 2/24

Indigo Diabetes Raises €7M in Investment

Facebook X LinkedIn Email
Silicon photonic startup Indigo Diabetes NV has closed a €7 million ($7.4 million) round of series A investment to support its development of an optical glucose monitor for diabetics.

Single-chip glucose sensor.
Single-chip glucose sensor. Courtesy of Indigo Diabetes NV.

The company aims to use research from Ghent University and the imec electronics development center to replace conventional finger-prick blood tests with an implantable optical device.

“Licensing a series of new technologies from globally recognized research institutions UGent and imec enables Indigo to enter the market with the first needle-free and calibration-free glucose sensor,” said Danaë Delbeke, founder of Indigo and member of the Photonics Research Group at Ghent.

Thuja Capital is the lead investor.
Meadowlark Optics - Building system MR 7/23

Published: January 2017
Indigo Diabetesglucose monitorEuropeBusinessBiophotonicsSensors & DetectorsRapidScan

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.